Lymphocyte modulation with FTY720 improves hemorrhagic shock survival in swine

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Hawksworth, Jason S ^a,b   Graybill, J Christopher ^a,b   Brown, Trevor S ^a   Wallace, Shannon M ^d   Davis, Thomas A ^a   Tadaki, Doug K ^a,c   Elster, Eric A ^a,b,c  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; MESSENGER RNA; MYELOPEROXIDASE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PEROXIDASE; PRIMER DNA; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HEMORRHAGIC SHOCK; IMMUNE INJURY; IMMUNE RESPONSE GENE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFECTION; LEUKOCYTE COUNT; LIVER INJURY; LUNG PARENCHYMA; LYMPHOCYTE FUNCTION; LYMPHOCYTE SEQUESTRATION; MALE; MESENTERY LYMPH NODE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; OVERALL SURVIVAL; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL RATE; SWINE; WOUND HEALING IMPAIRMENT; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LIVER; LYMPH NODE; LYMPHOCYTE; NEUTROPHIL; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SWINE DISEASE;

ANIMALIA; SUIDAE; SUS;

ANALYSIS OF VARIANCE; ANIMALS; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LIVER; LYMPH NODES; LYMPHOCYTES; MALE; NEUTROPHILS; PEROXIDASE; PROPYLENE GLYCOLS; REAL-TIME POLYMERASE CHAIN REACTION; SHOCK, HEMORRHAGIC; SPHINGOSINE; SPLEEN; SWINE; SWINE DISEASES;

EID: 84860487214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034224     Document Type: Article

References (39)

1. Moore FA, Moore EE, (2004) Postinjury multiple organ failure. In: Moore EE, Feliciano DV, Mattox KL, editors. New York McGraw-Hill.
2. De AK, Kodys KM, Pellegrini J, Yeh B, Furse RK, et al. (2000) Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression. Clin Immunol 96: 52-66.
3. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, et al. (2003) Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med 31: 1722-1729.
4. Bandyopadhyay G, De A, Laudanski K, Li F, Lentz C, et al. (2007) Negative signaling contributes to T-cell anergy in trauma patients. Crit Care Med 35: 794-801.
5. Rabb H, Daniels F, O'Donnell M, Haq M, Saba SR, et al. (2000) Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 279: F525-531.
6. Horie Y, Wolf R, Chervenak RP, Jennings SR, Granger DN, (1999) T-lymphocytes contribute to hepatic leukostasis and hypoxic stress induced by gut ischemia-reperfusion. Microcirculation 6: 267-280.
7. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, et al. (1997) CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100: 279-289.
8. Le Moine O, Louis H, Demols A, Desalle F, Demoor F, et al. (2000) Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology 31: 1266-1274.
9. Caldwell CC, Tschoep J, Lentsch AB, (2007) Lymphocyte function during hepatic ischemia/reperfusion injury. J Leukoc Biol 82: 457-464.
10. Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362: 387-401.
11. Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362: 402-415.
12. Rivera J, Proia RL, Olivera A, (2008) The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 8: 753-763.
13. Arnaud F, Handrigan M, Hammett M, Philbin N, Rice J, et al. (2006) Coagulation patterns following haemoglobin-based oxygen carrier resuscitation in severe uncontrolled haemorrhagic shock in swine. Transfus Med 16: 290-302.
14. Hawksworth JS, Elster EA, Fryer D, Sheppard F, Morthole V, et al. (2009) Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine. J Thromb Haemost 7: 1663-1671.
15. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR, (1997) Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 51: 1463-1468.
16. Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, et al. (1995) Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma 39: 411-417.
17. Weiss SJ, (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365-376.
18. Pallister I, Dent C, Topley N, (2002) Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Crit Care Med 30: 1717-1721.
19. Windsor AC, Mullen PG, Fowler AA, Sugerman HJ, (1993) Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 80: 10-17.
20. Lenz A, Franklin GA, Cheadle WG, (2007) Systemic inflammation after trauma. Injury 38: 1336-1345.
21. Harlan JM, Winn RK, (2002) Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med 30: S214-219.
22. Rhee P, Morris J, Durham R, Hauser C, Cipolle M, et al. (2000) Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: results of a phase II clinical trial. Traumatic Shock Group. J Trauma 49: 611-619; discussion 619-620.
23. Yonekawa K, Harlan JM, (2005) Targeting leukocyte integrins in human diseases. J Leukoc Biol 77: 129-140.
24. Huang Y, Rabb H, Womer KL, (2007) Ischemia-reperfusion and immediate T cell responses. Cell Immunol 248: 4-11.
25. Matzinger P, (1998) An innate sense of danger. Semin Immunol 10: 399-415.
26. Kokura S, Wolf RE, Yoshikawa T, Granger DN, Aw TY, (2000) Postanoxic T lymphocyte-endothelial cell interactions induce tumor necrosis factor-alpha production and neutrophil adhesion: role of very late antigen-4/vascular cell adhesion molecule-1. Circ Res 86: 1237-1244.
27. Kokura S, Wolf RE, Yoshikawa T, Ichikawa H, Granger DN, et al. (2000) Endothelial cells exposed to anoxia/reoxygenation are hyperadhesive to T-lymphocytes: kinetics and molecular mechanisms. Microcirculation 7: 13-23.
28. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, et al. (2001) Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108: 1283-1290.
29. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL, (1997) The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 100: 1199-1203.
30. Brinkmann V, Pinschewer DD, Feng L, Chen S, (2001) FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 72: 764-769.
31. Brinkmann V, Lynch KR, (2002) FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 14: 569-575.
32. Brinkmann V, Cyster JG, Hla T, (2004) FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4: 1019-1025.
33. Dragun D, Bohler T, Nieminen-Kelha M, Waiser J, Schneider W, et al. (2004) FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int 65: 1076-1083.
34. Hawksworth JS, Brown TS, Fryer D, Gage F, Graybill JC, et al. (2009) Lymphocyte Immunomodulation Improves Survival in Experimental Hemorrhagic Shock. Abstract. Journal of Surgical Research 151: 267.
35. Peters SL, Alewijnse AE, (2007) Sphingosine-1-phosphate signaling in the cardiovascular system. Curr Opin Pharmacol 7: 186-192.
36. Zhao Y, Man K, Lo CM, Ng KT, Li XL, et al. (2004) Attenuation of small-for-size liver graft injury by FTY720: significance of cell-survival Akt signaling pathway. Am J Transplant 4: 1399-1407.
37. Nugent D, Xu Y, (2000) Sphingosine-1-phosphate: characterization of its inhibition of platelet aggregation. Platelets 11: 226-232.
38. Koyrakh L, Roman MI, Brinkmann V, Wickman K, (2005) The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I. Am J Transplant 5: 529-536.
39. Weaver TA, Kirk AD, (2007) Alemtuzumab. Transplantation 84: 1545-1547.